Abstract
<div>Abstract<p>miRNAs are key players in the integrated regulation of cellular processes and shape many of the functional properties that define the “cancer stem cell” (CSC) phenotype. Little is known, however, about miRNAs that regulate such properties in human colorectal carcinoma. In this study, we compared the expression levels of 754 miRNAs between paired samples of EpCAM<sup>+</sup>/CD44<sup>+</sup> cancer cells (enriched in CSCs) and EpCAM<sup>+</sup>/CD44<sup>neg</sup> cancer cells (with CSC depletion) sorted in parallel from human primary colorectal carcinomas and identified miR-221 as the miRNA that displayed the highest level of preferential expression in EpCAM<sup>+</sup>/CD44<sup>+</sup> cancer cells. High levels of miR-221 expression were associated with Lgr5<sup>+</sup> cells in mouse colon crypts and reduced survival in patients with colorectal carcinoma. Constitutive overexpression of miR-221 enhanced organoid-forming capacity of both conventional colorectal carcinoma cell lines and patient-derived xenografts (PDX) <i>in vitro</i>. Importantly, constitutive downregulation of miR-221 suppressed organoid-forming capacity <i>in vitro</i> and substantially reduced the tumorigenic capacity of CSC populations from PDX lines <i>in vivo</i>. Finally, the most abundant splicing isoform of the human <i>Quaking</i> (<i>QKI</i>) gene, <i>QKI-5</i>, was identified as a functional target of miR-221; overexpression of miR-221–reduced QKI-5 protein levels in human colorectal carcinoma cells. As expected, overexpression of QKI-5 suppressed organoid-forming capacity <i>in vitro</i> and tumorigenic capacity of colorectal carcinoma PDX cells <i>in vivo</i>. Our study reveals a mechanistic link between miR-221 and QKI and highlights their key role in regulating CSC properties in human colorectal cancer.</p>Significance:<p>These findings uncover molecular mechanisms underlying the maintenance of cancer stem cell properties in colon cancer.</p></div>
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have